<qa>  What is the exception to the NCI-CTCAE version 4.03 Grade 1- Participants who have had chemotherapy within 14 days prior registration or those who have not recovered from all toxicities related to prior anticancer therapies to NCI-CTCAE version 4.03 Grade 1 Exception to this criterion: patients with any grade of alopecia are allowed to enter the study. There is no washout period required for Trastuzumab. 